Financhill
Back

Molecular Partners AG Vs. CRISPR Therapeutics AG Industry Stock Comparison

Sell
21

MOLN
Molecular Partners AG

Last Price:
5.34
Seasonality Move:
28.54%
Sell
42

CRSP
CRISPR Therapeutics AG

Last Price:
46.30
Seasonality Move:
12.87%
Sell
21
Molecular Partners AG (MOLN) is a Sell

Is Molecular Partners AG a Buy, Sell or Hold?

  • The current Molecular Partners AG [MOLN] share price is $5.20. The Score for MOLN is 21, which is 58% below its historic median score of 50, and infers higher risk than normal.
  • MOLN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
42
CRISPR Therapeutics AG (CRSP) is a Sell

Is CRISPR Therapeutics AG a Buy, Sell or Hold?

  • The current CRISPR Therapeutics AG [CRSP] share price is $46.29. The Score for CRSP is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • CRSP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

MOLN Stock Price Chart

What is Molecular Partners AG's stock price today?

  • The Molecular Partners AG share price today is $5.20
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MOLN is experiencing buying pressure, which is a positive indicator for future bullish movement.

CRSP Stock Price Chart

What is CRISPR Therapeutics AG's stock price today?

  • The CRISPR Therapeutics AG share price today is $46.29
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CRSP is experiencing slight selling pressure.

MOLN Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.03 Sell
Relative Strength Index (14 RSI): 44.42 Sell
Chaikin Money Flow: -27389 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CRSP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.25 Sell
Relative Strength Index (14 RSI): 42.46 Sell
Chaikin Money Flow: -171965 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

MOLN Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 5.51 Sell
20-day SMA: 5.85 Sell
50-day SMA: 5.37 Sell
200-day SMA: 5.18 Buy
8-day EMA: 5.53 Sell
20-day EMA: 5.64 Sell
50-day EMA: 5.62 Sell
200-day EMA: 5.44 Sell

CRSP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 47.81 Sell
20-day SMA: 49.18 Sell
50-day SMA: 47.95 Sell
200-day SMA: 57.24 Sell
8-day EMA: 47.79 Sell
20-day EMA: 48.5 Sell
50-day EMA: 48.63 Sell
200-day EMA: 53.32 Sell

Molecular Partners AG Earnings Growth & MOLN Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.08 per share.

CRISPR Therapeutics AG Earnings Growth & CRSP Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.16 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.19 per share, and an increase next year of $0.13 per share.

Molecular Partners AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

CRISPR Therapeutics AG Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):